|
US6455690B1
(en)
*
|
1996-10-16 |
2002-09-24 |
Robert Tam |
L-8-oxo-7-propyl-7,8-dihydro-(9H)-guanosine
|
|
AU743366B2
(en)
*
|
1997-01-17 |
2002-01-24 |
Icn Pharmaceuticals, Inc. |
Novel nucleosides
|
|
GB9821058D0
(en)
|
1998-09-28 |
1998-11-18 |
Univ Cardiff |
Chemical compound
|
|
CA2381297A1
(en)
*
|
1999-08-27 |
2001-04-19 |
Esmir Gunic |
Pyrrolo¬2,3-d|pyrimidine nucleoside analogs
|
|
US7638496B2
(en)
|
2000-02-15 |
2009-12-29 |
Valeant Pharmaceuticals North America |
Nucleoside analogs with carboxamidine modified monocyclic base
|
|
US7094770B2
(en)
|
2000-04-13 |
2006-08-22 |
Pharmasset, Ltd. |
3′-or 2′-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
|
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
CZ301182B6
(cs)
|
2000-05-26 |
2009-12-02 |
Idenix (Cayman) Limited |
Použití nukleosidových derivátu pro výrobu farmaceutických prostredku pro lécení infekcí vyvolaných flaviviry a pestiviry
|
|
US6680059B2
(en)
|
2000-08-29 |
2004-01-20 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
|
US7022830B2
(en)
|
2000-08-17 |
2006-04-04 |
Tripep Ab |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
|
|
RU2286172C2
(ru)
|
2000-08-17 |
2006-10-27 |
Трипеп Аб |
Вакцины, содержащие рибавирин, и способы их использования
|
|
AU2001290178A1
(en)
|
2000-08-17 |
2002-02-25 |
Tripep Ab |
A hepatitis c virus non-structural ns3/4a fusion gene
|
|
US20030008841A1
(en)
*
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
|
IL155367A0
(en)
*
|
2000-10-23 |
2003-12-23 |
Smithkline Beecham Corp |
NOVEL 2,4,8-TRISUBSTITUTED-8h-PYRIDO[2,3,-d]PYRIMIDIN-7-ONE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, PROCESSES FOR THE PREPARATION THEREOF, AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR TREATING CSBP/p38 KINASE MEDIATED DISEASES
|
|
US8481712B2
(en)
|
2001-01-22 |
2013-07-09 |
Merck Sharp & Dohme Corp. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
GB0114286D0
(en)
*
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
|
US7049303B2
(en)
*
|
2001-11-07 |
2006-05-23 |
Medical Research Council |
Inhibition of viruses
|
|
US7321033B2
(en)
*
|
2001-11-27 |
2008-01-22 |
Anadys Pharmaceuticals, Inc. |
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
|
|
UA79764C2
(en)
*
|
2001-11-27 |
2007-07-25 |
Anadys Pharmaceuticals Inc |
3-?-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
|
|
US20030153744A1
(en)
*
|
2001-12-21 |
2003-08-14 |
Micrologix Biotech Inc. |
Anti-viral 7-deaza L-nucleosides
|
|
TW200500375A
(en)
*
|
2002-06-28 |
2005-01-01 |
Idenix Cayman Ltd |
Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae
|
|
RU2005102096A
(ru)
*
|
2002-06-28 |
2005-11-20 |
Айденикс (Кайман) Лимитед (Ky) |
2'и 3'-нуклеозидные пролекарства для лечения инфекций, вызываемых flaviviridae
|
|
WO2004002422A2
(en)
|
2002-06-28 |
2004-01-08 |
Idenix (Cayman) Limited |
2’-c-methyl-3’-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
|
CN101172993A
(zh)
|
2002-06-28 |
2008-05-07 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
|
|
IL166640A0
(en)
|
2002-08-01 |
2006-01-15 |
Pharmasset Ltd |
Compounds with the bicyclo Ä4.2.1Ü nonane system for the treatment of flaviviridae infections
|
|
DE10238724A1
(de)
*
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
|
DE10238722A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
|
|
CN1293884C
(zh)
*
|
2002-10-29 |
2007-01-10 |
南京长澳医药科技有限公司 |
6－甲氧基双脱氧鸟苷在制备抗乙肝药物中的应用
|
|
ES2624353T3
(es)
|
2002-11-15 |
2017-07-13 |
Idenix Pharmaceuticals Llc |
2'-Metil nucleósidos en combinación con interferón y mutación de Flaviviridae
|
|
RU2005121904A
(ru)
|
2002-12-12 |
2006-01-20 |
Айденикс (Кайман) Лимитед (Ky) |
Способ получения 2`-разветвленных нуклеозидов
|
|
US20050049204A1
(en)
*
|
2003-03-28 |
2005-03-03 |
Otto Michael J. |
Compounds for the treatment of flaviviridae infections
|
|
US8044060B2
(en)
|
2003-05-09 |
2011-10-25 |
Boehringer Ingelheim International Gmbh |
6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory
|
|
DE10320785A1
(de)
*
|
2003-05-09 |
2004-11-25 |
Bayer Healthcare Ag |
6-Arylmethyl-substituierte Pyrazolopyrimidine
|
|
WO2004113357A2
(en)
*
|
2003-05-20 |
2004-12-29 |
The Board Of Trustees Of The University Of Illinois |
Nucleoside analog inhibitors of reverse transcriptase
|
|
WO2005020885A2
(en)
*
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
|
|
EP4032897B1
(en)
|
2003-05-30 |
2025-01-29 |
Gilead Pharmasset LLC |
Modified fluorinated nucleoside analogues
|
|
ATE478886T1
(de)
|
2003-07-25 |
2010-09-15 |
Idenix Pharmaceuticals Inc |
Purin nucleoside für die behandlung von durch flavividrae verursachten krankheiten, einschliesslich hepatitis c
|
|
WO2005018330A1
(en)
*
|
2003-08-18 |
2005-03-03 |
Pharmasset, Inc. |
Dosing regimen for flaviviridae therapy
|
|
CN103145715B
(zh)
|
2003-10-14 |
2016-08-03 |
F·霍夫曼-罗须公司 |
作为hcv复制抑制剂的巨环羧酸和酰基磺酰胺
|
|
DE102004001873A1
(de)
|
2004-01-14 |
2005-09-29 |
Bayer Healthcare Ag |
Cyanopyrimidinone
|
|
US20050182252A1
(en)
|
2004-02-13 |
2005-08-18 |
Reddy K. R. |
Novel 2'-C-methyl nucleoside derivatives
|
|
CN101023094B
(zh)
*
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
|
EP1789074A4
(en)
*
|
2004-08-09 |
2009-08-12 |
Alios Biopharma Inc |
PROTEASE-RESISTANT HYPERGLYCOSYL SYNTHETIC POLYPEPTIDE VARIANTS, ORAL FORMULATIONS AND METHODS OF USING THE SAME
|
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
|
WO2006031725A2
(en)
|
2004-09-14 |
2006-03-23 |
Pharmasset, Inc. |
Preparation of 2'fluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
|
|
KR20070100237A
(ko)
|
2004-10-29 |
2007-10-10 |
바이오크리스트 파마수티컬즈, 인코퍼레이티드 |
치료용 푸로피리미딘 및 티에노피리미딘
|
|
DK2561872T3
(en)
*
|
2004-12-17 |
2014-12-08 |
Anadys Pharmaceuticals Inc |
3,5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED 3H-OXAZOLO- [4,5-d] PYRIMIDIN-2-ON COMPOUNDS AND PRODRUGS THEREOF
|
|
ES2345997T3
(es)
|
2005-01-14 |
2010-10-07 |
Janssen Pharmaceutica Nv |
Pirazolopiramidinas como inhibidores de las quinasas del ciclo celular.
|
|
AU2006205851A1
(en)
|
2005-01-14 |
2006-07-20 |
Janssen Pharmaceutica N.V. |
5-membered annelated heterocyclic pyrimidines as kinase inhibitors
|
|
RU2393866C2
(ru)
*
|
2005-03-17 |
2010-07-10 |
Проекто Де Биомедисина Сима, С.Л. |
Применение 5'-метилтиоаденозина (мта) для предотвращения и/или лечения аутоиммунных заболеваний и/или отторжения трансплантата
|
|
DE602005016729D1
(de)
|
2005-03-17 |
2009-10-29 |
Proyecto Biomedicina Cima Sl |
Verwendung von 5'-methylthioadenosin zur prävention und/oder behandlung von autoimmunkrankheiten und/oder transplantatabstossung
|
|
JP2008537937A
(ja)
*
|
2005-03-25 |
2008-10-02 |
グラクソ グループ リミテッド |
ピリド［２，３−ｄ］ピリミジン−７−オンおよび３，４−ジヒドロピリミド［４，５−ｄ］ピリミジン−２（１Ｈ）−オン誘導体の製造方法
|
|
PE20100737A1
(es)
*
|
2005-03-25 |
2010-11-27 |
Glaxo Group Ltd |
Nuevos compuestos
|
|
WO2007010515A1
(en)
*
|
2005-07-22 |
2007-01-25 |
Giuliani International Limited |
Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation
|
|
ITRM20050391A1
(it)
*
|
2005-07-22 |
2007-01-23 |
Giuliani Spa |
Composti analoghi della 6-tioguanosina trifosfato, loro uso in campo medico e procedimento per la loro preparazione.
|
|
JP5117391B2
(ja)
|
2005-11-21 |
2013-01-16 |
アナディス ファーマシューティカルズ インク |
５−アミノ−３Ｈ−チアゾロ［４，５−ｄ］ピリミジン−２−オンを調製するための新規な方法
|
|
MX2008016518A
(es)
*
|
2006-06-22 |
2009-01-19 |
Anadys Pharmaceuticals Inc |
Profarmacos de 5-amino-3-(3'-desoxi-beta-d-ribofuranosil)-tiazolo[ 4,5-d]pirimidin-2,7-dion.
|
|
DE602007012881D1
(en)
|
2006-07-18 |
2011-04-14 |
Anadys Pharmaceuticals Inc |
Carbonat- und carbamat-prodrugs von thiazolo ä4,5-dü-pyrimidinen
|
|
JP2010510171A
(ja)
*
|
2006-08-21 |
2010-04-02 |
ユナイテッド セラピューティクス コーポレーション |
ウイルス感染症の治療のための併用療法
|
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
|
EP2185195A2
(en)
|
2007-08-16 |
2010-05-19 |
Tripep Ab |
Immunogen platform
|
|
EP2048151A1
(en)
*
|
2007-10-10 |
2009-04-15 |
Cilag AG |
Method for producing nucleosides by direct glycosylation of the nucleoside base
|
|
PE20091211A1
(es)
|
2007-11-30 |
2009-09-14 |
Boehringer Ingelheim Int |
Derivados de pirazolopirimidina como moduladores de pde9a
|
|
US8227431B2
(en)
|
2008-03-17 |
2012-07-24 |
Hetero Drugs Limited |
Nucleoside derivatives
|
|
ES2329327B1
(es)
|
2008-03-19 |
2010-09-17 |
Proyecto De Biomedicina Cima, S.L. |
Combinaciones sinergicas de 5'-metiltioadenosina.
|
|
UA105362C2
(en)
|
2008-04-02 |
2014-05-12 |
Бьорингер Ингельхайм Интернациональ Гмбх |
1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
|
|
US20100004526A1
(en)
*
|
2008-06-04 |
2010-01-07 |
Eigen, Inc. |
Abnormality finding in projection images
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
JP5654990B2
(ja)
*
|
2008-08-20 |
2015-01-14 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
アゾ置換ピリジンおよびピリミジン誘導体ならびにそれらのウイルス感染の治療における使用
|
|
CA2736304A1
(en)
|
2008-09-08 |
2010-03-11 |
Boehringer Ingelheim International Gmbh |
Pyrazolopyrimidines and their use for the treatment of cns disorders
|
|
WO2010027935A1
(en)
|
2008-09-08 |
2010-03-11 |
Merck Sharp & Dohme Corp. |
Ahcy hydrolase inhibitors for treatment of hyper homocysteinemia
|
|
EP2341924A4
(en)
|
2008-10-02 |
2013-01-23 |
David Gladstone Inst |
METHOD FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTIONS
|
|
SG172359A1
(en)
|
2008-12-23 |
2011-07-28 |
Pharmasset Inc |
Nucleoside phosphoramidates
|
|
US8551973B2
(en)
|
2008-12-23 |
2013-10-08 |
Gilead Pharmasset Llc |
Nucleoside analogs
|
|
NZ593647A
(en)
|
2008-12-23 |
2013-08-30 |
Gilead Pharmasset Llc |
Synthesis of purine nucleosides
|
|
EP2408449A4
(en)
|
2009-03-18 |
2012-08-08 |
Univ Leland Stanford Junior |
METHOD AND COMPOSITIONS FOR TREATING FLAVIVIRIDAE VIRUS INFECTIONS
|
|
GEP20146098B
(en)
|
2009-03-31 |
2014-05-27 |
Boehringer Ingelheim Int |
1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their usage as pde9a modulators
|
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
|
TWI598358B
(zh)
|
2009-05-20 |
2017-09-11 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
|
TW201118099A
(en)
|
2009-08-12 |
2011-06-01 |
Boehringer Ingelheim Int |
New compounds for the treatment of CNS disorders
|
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
|
JP2013527145A
(ja)
|
2010-03-31 |
2013-06-27 |
ギリード・ファーマセット・エルエルシー |
リン含有活性化剤の立体選択的合成
|
|
US8481711B2
(en)
|
2010-07-06 |
2013-07-09 |
Hidenori Kamanishi |
Neurite outgrowth agent
|
|
MX344770B
(es)
|
2010-08-12 |
2017-01-06 |
Boehringer Ingelheim Int Gmbh * |
Derivados de 6-cicloalquil-1,5-dihidro-pirazolo (3,4-d) pirimidin-4-onas y su uso como inhibidores de pde9a.
|
|
WO2012040124A1
(en)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
|
PT3042910T
(pt)
|
2010-11-30 |
2019-04-16 |
Gilead Pharmasset Llc |
2'-espiro-nucleósidos para utilização na terapia da hepatite c
|
|
US20130040971A1
(en)
|
2011-02-14 |
2013-02-14 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders
|
|
US8809345B2
(en)
|
2011-02-15 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
|
|
WO2012142075A1
(en)
|
2011-04-13 |
2012-10-18 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
US9408863B2
(en)
|
2011-07-13 |
2016-08-09 |
Merck Sharp & Dohme Corp. |
5′-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases
|
|
CA2840242C
(en)
|
2011-09-16 |
2019-03-26 |
Gilead Sciences, Inc. |
Methods for treating hcv
|
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
|
BR112014013649A2
(pt)
|
2011-12-06 |
2020-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
métodos e agentes para o tratamento de doenças virais e usos dos referidos agentes
|
|
AU2012358803C1
(en)
|
2011-12-22 |
2019-12-19 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
USRE48171E1
(en)
|
2012-03-21 |
2020-08-25 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
MX2014014323A
(es)
|
2012-05-25 |
2015-02-12 |
Janssen R & D Ireland |
Nucleosidos de espirooxetano de uracilo.
|
|
JP6284547B2
(ja)
|
2012-12-21 |
2018-02-28 |
アリオス バイオファーマ インク． |
置換ヌクレオシド、置換ヌクレオチドおよびそれらの類似体
|
|
KR20200060782A
(ko)
|
2013-01-31 |
2020-06-01 |
길리애드 파마셋 엘엘씨 |
두 항바이러스 화합물의 병용 제형물
|
|
EP3650014B1
(en)
|
2013-08-27 |
2021-10-06 |
Gilead Pharmasset LLC |
Combination formulation of two antiviral compounds
|
|
EP3055319A4
(en)
|
2013-10-11 |
2018-01-10 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
JP6469692B2
(ja)
*
|
2013-12-09 |
2019-02-13 |
ユーシービー バイオファルマ エスピーアールエル |
Ｔｎｆ活性のモジュレーターとしてのイミダゾピリジン誘導体
|
|
WO2015143712A1
(en)
|
2014-03-28 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
4'-substituted nucleoside reverse transcriptase inhibitors
|
|
CN104497083B
(zh)
*
|
2014-05-12 |
2017-07-07 |
河南师范大学 |
具有抗寄生虫活性的核苷‑苯基丙烯酮杂化体及其制备方法和应用
|
|
EP3197457B1
(en)
|
2014-09-26 |
2022-11-09 |
Riboscience LLC |
4'-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus rna replication
|
|
EP3230298B1
(en)
|
2014-12-08 |
2021-01-20 |
F.Hoffmann-La Roche Ag |
3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection
|
|
MY190867A
(en)
|
2015-03-06 |
2022-05-13 |
Atea Pharmaceuticals Inc |
? -d-2'-deoxy-2'-?-fluoro-2'- ? -c-substituted-2-modified-n6-substituted purine nucleotides for hcv treatment
|
|
ES2798598T3
(es)
|
2015-03-16 |
2020-12-11 |
Hoffmann La Roche |
Tratamiento combinado con un agonista de TLR7 y un inhibidor de ensamblaje de la cápside del VHB
|
|
CN107743491B
(zh)
|
2015-05-08 |
2020-08-21 |
豪夫迈·罗氏有限公司 |
用于治疗和预防病毒感染的新的氧硫杂环戊烷甲酸及其衍生物
|
|
WO2016180743A1
(en)
|
2015-05-12 |
2016-11-17 |
F. Hoffmann-La Roche Ag |
Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
|
|
CN104844673B
(zh)
*
|
2015-06-04 |
2017-09-08 |
新乡学院 |
一种制备天然核苷水粉蕈素的方法
|
|
JP6839104B2
(ja)
|
2015-06-30 |
2021-03-03 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
ウイルス感染の治療及び予防のための新規な置換アミノチアゾロピリミジンジオン
|
|
WO2017053216A2
(en)
|
2015-09-23 |
2017-03-30 |
Merck Sharp & Dohme Corp. |
4'-substituted nucleoside reverse transcriptase inhibitors and preparations thereof
|
|
FI3433257T3
(fi)
|
2016-03-24 |
2024-01-08 |
Novartis Ag |
Alkynyylinukleosidianalogeja ihmisen rinoviruksen estäjinä
|
|
US10202412B2
(en)
|
2016-07-08 |
2019-02-12 |
Atea Pharmaceuticals, Inc. |
β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections
|
|
PL3512863T3
(pl)
|
2016-09-07 |
2022-04-04 |
Atea Pharmaceuticals, Inc. |
2'-Podstawione-N6-podstawione nukleotydy purynowe do leczenia zakażeń wirusem RNA
|
|
AU2018205994B2
(en)
|
2017-01-06 |
2021-09-09 |
F. Hoffmann-La Roche Ag |
Process for the preparation of 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds
|
|
CN108329372B
(zh)
*
|
2017-01-20 |
2022-07-26 |
浙江省亚热带作物研究所 |
N6-(2-羟乙基)腺苷及其衍生物在制备治疗痛风药物中的应用
|
|
IL295609B2
(en)
|
2017-02-01 |
2023-11-01 |
Atea Pharmaceuticals Inc |
Nucleotide hemisulfate salt for the treatment of hepatitis C virus
|
|
US11040975B2
(en)
|
2017-12-08 |
2021-06-22 |
Merck Sharp & Dohme Corp. |
Carbocyclic nucleoside reverse transcriptase inhibitors
|
|
CN112351799A
(zh)
|
2018-04-10 |
2021-02-09 |
阿堤亚制药公司 |
具有硬化的hcv感染患者的治疗
|
|
ES3001123T3
(es)
|
2018-05-25 |
2025-03-04 |
Primmune Therapeutics Inc |
Agonistas de TLR7
|
|
SG11202110742TA
(en)
|
2019-04-02 |
2021-10-28 |
Aligos Therapeutics Inc |
Compounds targeting prmt5
|
|
CN111973615A
(zh)
*
|
2019-05-22 |
2020-11-24 |
华东理工大学 |
一种治疗躁狂型精神障碍及精神分裂症的药物
|
|
KR20220150879A
(ko)
|
2019-11-26 |
2022-11-11 |
프리뮨 테라퓨틱스, 인크. |
Tlr7 효능제
|
|
TWI794742B
(zh)
|
2020-02-18 |
2023-03-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
TWI775313B
(zh)
|
2020-02-18 |
2022-08-21 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
AR121356A1
(es)
|
2020-02-18 |
2022-05-11 |
Gilead Sciences Inc |
Compuestos antivirales
|
|
US10874687B1
(en)
|
2020-02-27 |
2020-12-29 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against COVID-19
|
|
WO2021257863A1
(en)
|
2020-06-19 |
2021-12-23 |
Incyte Corporation |
Pyrrolotriazine compounds as jak2 v617f inhibitors
|
|
WO2021257857A1
(en)
|
2020-06-19 |
2021-12-23 |
Incyte Corporation |
Naphthyridinone compounds as jak2 v617f inhibitors
|
|
WO2022006457A1
(en)
|
2020-07-02 |
2022-01-06 |
Incyte Corporation |
Tricyclic urea compounds as jak2 v617f inhibitors
|
|
US11767323B2
(en)
|
2020-07-02 |
2023-09-26 |
Incyte Corporation |
Tricyclic pyridone compounds as JAK2 V617F inhibitors
|
|
WO2022046989A1
(en)
|
2020-08-27 |
2022-03-03 |
Incyte Corporation |
Tricyclic urea compounds as jak2 v617f inhibitors
|
|
US11919908B2
(en)
|
2020-12-21 |
2024-03-05 |
Incyte Corporation |
Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
|
|
WO2022182839A1
(en)
|
2021-02-25 |
2022-09-01 |
Incyte Corporation |
Spirocyclic lactams as jak2 v617f inhibitors
|
|
ES3028915T3
(en)
|
2021-04-16 |
2025-06-20 |
Gilead Sciences Inc |
Methods of preparing carbanucleosides using amides
|
|
BR112023026356A2
(pt)
|
2021-06-17 |
2024-03-05 |
Atea Pharmaceuticals Inc |
Método para tratar vírus da hepatite c ou uma condição resultante de uma infecção por hepatite c, combinação, uso da combinação, composição farmacêutica, e, kit para o tratamento de vírus da hepatite c
|
|
EP4387977A1
(en)
|
2021-08-18 |
2024-06-26 |
Gilead Sciences, Inc. |
Phospholipid compounds and methods of making and using the same
|
|
JP2025509672A
(ja)
|
2022-03-17 |
2025-04-11 |
インサイト・コーポレイション |
Ｊａｋ２ ｖ６１７ｆ阻害剤としての三環式尿素化合物
|